GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Common Stock

Genesystem Co (XKRX:363250) Common Stock : ₩0.0 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Common Stock?

Genesystem Co's quarterly common stock increased from Sep. 2023 (₩3,480.7 Mil) to Dec. 2023 (₩3,492.4 Mil) but then declined from Dec. 2023 (₩3,492.4 Mil) to Mar. 2024 (₩0.0 Mil).

Genesystem Co's annual common stock increased from Dec. 2021 (₩3,439.6 Mil) to Dec. 2022 (₩3,465.0 Mil) and increased from Dec. 2022 (₩3,465.0 Mil) to Dec. 2023 (₩3,492.4 Mil).


Genesystem Co Common Stock Historical Data

The historical data trend for Genesystem Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Common Stock Chart

Genesystem Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
368.50 2,671.67 3,439.59 3,464.99 3,492.44

Genesystem Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,464.99 3,480.70 3,480.70 3,492.44 -

Genesystem Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Genesystem Co (XKRX:363250) Business Description

Traded in Other Exchanges
N/A
Address
200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028
Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines